Salt of (S)-5-{3-[4-(4-Chloro-phenyl)-4 hydroxy-3,3-dimethyl-piperidin-1-yl] -prop- ylidene}-5,11-dihydro-10-oxa-1-aza dibenzo[a,d]cycloheptene-7-carboxylic acid

Abstract

The invention provides a physiological salt of compound having the formula: wherein R1 is halogen. The invention also provides composition comprising the compound, and method of treating diseases or disorders that comprise administering one or more of the compound to a subject in need thereof. The disclosed compound have CCR1 antagonist activity.